December 18, 2020 Recycling pays off for Mereo The company has spent five years buying in discontinued projects, and at last has managed to sell one of these on at a nice profit.
March 03, 2020 Roche move endorses Iteos’s Tigit widget A private Belgian biotech reckons Tigit is the new PD-1, a view Roche’s progress could validate.
January 31, 2020 Roche’s next immuno-oncology combo is a big bet on Tigit Almost in stealth mode the Swiss firm moves to begin a huge pivotal programme rivalling that of the IDO and IL-2 mechanisms.